- Home
- IVA vs TBMC Comparison
IVA vs TBMC Comparison
Compare IVA & TBMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- TBMC
- Stock Information
- Founded
- IVA 2011
- TBMC 2021
- Country
- IVA France
- TBMC United States
- Employees
- IVA N/A
- TBMC N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- TBMC Blank Checks
- Sector
- IVA Health Care
- TBMC Finance
- Exchange
- IVA Nasdaq
- TBMC Nasdaq
- Market Cap
- IVA 117.3M
- TBMC 98.6M
- IPO Year
- IVA 2020
- TBMC 2023
- Fundamental
- Price
- IVA $2.73
- TBMC $11.07
- Analyst Decision
- IVA Strong Buy
- TBMC
- Analyst Count
- IVA 3
- TBMC 0
- Target Price
- IVA $17.67
- TBMC N/A
- AVG Volume (30 Days)
- IVA 634.3K
- TBMC 19.6K
- Earning Date
- IVA 09-25-2024
- TBMC 01-01-0001
- Dividend Yield
- IVA N/A
- TBMC N/A
- EPS Growth
- IVA N/A
- TBMC 397.49
- EPS
- IVA N/A
- TBMC 0.20
- Revenue
- IVA $20,652,523.00
- TBMC N/A
- Revenue This Year
- IVA N/A
- TBMC N/A
- Revenue Next Year
- IVA $469.85
- TBMC N/A
- P/E Ratio
- IVA N/A
- TBMC $55.44
- Revenue Growth
- IVA N/A
- TBMC N/A
- 52 Week Low
- IVA $1.53
- TBMC $10.36
- 52 Week High
- IVA $4.75
- TBMC $11.61
- Technical
- Relative Strength Index (RSI)
- IVA 67.19
- TBMC 60.98
- Support Level
- IVA $2.19
- TBMC $10.87
- Resistance Level
- IVA $2.85
- TBMC $11.07
- Average True Range (ATR)
- IVA 0.18
- TBMC 0.00
- MACD
- IVA 0.11
- TBMC -0.00
- Stochastic Oscillator
- IVA 90.40
- TBMC 44.44
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About TBMC Trailblazer Merger Corporation I
Trailblazer Merger Corp I is a blank check company.